Total Funding
94
73
Total FundingPost-IPO Equity raised
Growth Score
5 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
13192
CareDx supports transplant care with diagnostics, transplant lab products, and services.
- John Hanna: President and CEOPast Role: Apton Biosystems, CEO
- Jessica Meng: CCOPast Role: Delfi Diagnostics, CCO & Advisor
About the Company
CareDx is a molecular diagnostics company. They offer noninvasive surveillance tests to help identify injuries and rule out rejection. They deliver solutions that support a broad spectrum of needs, from initial matching to post-transplant monitoring and care.
